Literature DB >> 25233383

Identifying cancer subjects with acute respiratory failure at high risk for intubation and mechanical ventilation.

Virginie Lemiale1, Jérôme Lambert2, Emmanuel Canet3, Djamel Mokart4, Frederic Pène5, Antoine Rabbat6, Achille Kouatchet7, François Vincent8, Fabrice Bruneel9, Didier Gruson10, Sylvie Chevret2, Elie Azoulay3.   

Abstract

BACKGROUND: We sought to identify risk factors for mechanical ventilation in patients with malignancies and acute respiratory failure (ARF).
METHODS: We analyzed data from a previous randomized controlled trial in which nonintubated oncology and hematology subjects with ARF were randomized to early bronchoalveolar lavage or routine care in 16 ICUs in France. Consecutive patients with malignancies were admitted to the ICU for ARF in 2005 and 2006 with no intervention.
RESULTS: During the study period, 219 patients were admitted to the ICU for ARF, and 8 patients were not included due to a nonintubation order. Data on the underlying disease, pulmonary involvement, and extrapulmonary organ dysfunctions were recorded at admission in the 211 remaining subjects. Ventilatory support included oxygen only (49 subjects), noninvasive ventilation (NIV) only (81 subjects), NIV followed by invasive mechanical ventilation (49 subjects), and first-line invasive mechanical ventilation (32 subjects). The 81 subjects who required invasive mechanical ventilation were compared with the 130 subjects who remained on oxygen or NIV. Factors associated with invasive mechanical ventilation by multivariate analysis were the oxygen flow required at ICU admission, the number of quadrants involved on chest x-ray, and hemodynamic dysfunction. Mortality rates for subjects who had NIV failure were 65.3% compared with 50% for subjects who were first-line intubated (P = .34).
CONCLUSIONS: In cancer patients with ARF, hypoxemia, extent of pulmonary infiltration on chest x-ray, or hemodynamic dysfunction are risk factors for invasive mechanical ventilation. Mortality was not significantly different between NIV failure and first-line intubation.
Copyright © 2014 by Daedalus Enterprises.

Entities:  

Keywords:  cancer mechanical ventilation; immunosuppression; noninvasive ventilation; outcome; respiratory failure

Mesh:

Year:  2014        PMID: 25233383     DOI: 10.4187/respcare.02693

Source DB:  PubMed          Journal:  Respir Care        ISSN: 0020-1324            Impact factor:   2.258


  8 in total

1.  New puzzles for the use of non-invasive ventilation for immunosuppressed patients.

Authors:  Carmen Sílvia Valente Barbas; Ary Serpa Neto
Journal:  J Thorac Dis       Date:  2016-01       Impact factor: 2.895

2.  High-flow nasal cannula failure in critically ill cancer patients with acute respiratory failure: Moving from avoiding intubation to avoiding delayed intubation.

Authors:  Colombe Saillard; Jérôme Lambert; Morgane Tramier; Laurent Chow-Chine; Magali Bisbal; Luca Servan; Frederic Gonzalez; Jean-Manuel de Guibert; Marion Faucher; Antoine Sannini; Djamel Mokart
Journal:  PLoS One       Date:  2022-06-29       Impact factor: 3.752

3.  Early non-invasive ventilation for acute respiratory failure in immunocompromised patients (IVNIctus): study protocol for a multicenter randomized controlled trial.

Authors:  Virginie Lemiale; Matthieu Resche-Rigon; Elie Azoulay
Journal:  Trials       Date:  2014-09-25       Impact factor: 2.279

4.  Severe varicella-zoster virus pneumonia: a multicenter cohort study.

Authors:  Adrien Mirouse; Philippe Vignon; Prescillia Piron; René Robert; Laurent Papazian; Guillaume Géri; Pascal Blanc; Christophe Guitton; Claude Guérin; Naïke Bigé; Antoine Rabbat; Aurélie Lefebvre; Keyvan Razazi; Muriel Fartoukh; Eric Mariotte; Lila Bouadma; Jean-Damien Ricard; Amélie Seguin; Bertrand Souweine; Anne-Sophie Moreau; Stanislas Faguer; Arnaud Mari; Julien Mayaux; Francis Schneider; Annabelle Stoclin; Pierre Perez; Julien Maizel; Charles Lafon; Frédérique Ganster; Laurent Argaud; Christophe Girault; François Barbier; Lucien Lecuyer; Jérôme Lambert; Emmanuel Canet
Journal:  Crit Care       Date:  2017-06-07       Impact factor: 9.097

5.  Severe diffuse alveolar hemorrhage related to autoimmune disease: a multicenter study.

Authors:  Adrien Mirouse; Antoine Parrot; Vincent Audigier; Alexandre Demoule; Julien Mayaux; Guillaume Géri; Eric Mariotte; Nicolas Bréchot; Nicolas de Prost; Mathieu Vautier; Mathilde Neuville; Naïke Bigé; Etienne de Montmollin; Patrice Cacoub; Matthieu Resche-Rigon; Jacques Cadranel; David Saadoun
Journal:  Crit Care       Date:  2020-05-18       Impact factor: 9.097

Review 6.  Acute respiratory failure in immunocompromised adults.

Authors:  Elie Azoulay; Djamel Mokart; Achille Kouatchet; Alexandre Demoule; Virginie Lemiale
Journal:  Lancet Respir Med       Date:  2018-12-07       Impact factor: 30.700

Review 7.  Management strategy for hematological malignancy patients with acute respiratory failure.

Authors:  Li Jiang; Qunfang Wan; Hongbing Ma
Journal:  Eur J Med Res       Date:  2021-09-17       Impact factor: 2.175

8.  The effects of a 2-h trial of high-flow oxygen by nasal cannula versus Venturi mask in immunocompromised patients with hypoxemic acute respiratory failure: a multicenter randomized trial.

Authors:  Virginie Lemiale; Djamel Mokart; Julien Mayaux; Jérôme Lambert; Antoine Rabbat; Alexandre Demoule; Elie Azoulay
Journal:  Crit Care       Date:  2015-11-02       Impact factor: 9.097

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.